Table 2 Comparison of the non-massive ascites group with the massive ascites group
|  |  | Non-massive ascites group (N = 10) | Massive ascites group (N = 23) | p value |
|---|---|---|---|---|
Recipient characteristics | age (years) | 45 (34–58) | 54 (47–62) | 0.1580 |
male sex | 5 (50%) | 12 (36.4%) | 0.9086 | |
body weight (kg) | 67.5 (57.2–71.8) | 54.6 (52.0–67.0) | 0.0525 | |
Child–Pugh score | 8 (6–10) | 10 (9–12) | 0.0089 | |
MELD score | 13 (8–16) | 16 (10–24) | 0.0593 | |
preoperative ascites | 1 (10%) | 12 (36.4%) | 0.0227 | |
Clinical parameters at ICU admission | body temperature (°C) | 37.5 (37.2–37.8) | 37.0 (36.5–37.5) | 0.0544 |
heart rate (/min) | 98 (93–102) | 102 (95–116) | 0.1580 | |
mean arterial pressure (mmHg) | 86 (76–99) | 72 (64–75) | 0.0025 | |
usage of vasoactive agents | 1 (10%) | 10 (43.5%) | 0.0608 | |
lactate (mmol/L) | 4.7 (1.9–9.0) | 5.4 (3.2–9.5) | 0.4929 | |
total bilirubin (mg/dL) | 2.4 (1.1–3.8) | 3.2 (2.4–6.7) | 0.0848 | |
PT-INR | 1.32 (1.22–1.43) | 1.37 (1.27–1.50) | 0.4804 | |
Q-CRT (sec) | 1.17 (1.03–1.49) | 2.25 (1.68–3.12) | 0.0061 | |
ΔAb | 0.097 (0.067–0.124) | 0.060 (0.040–0.088) | 0.0109 | |
early allograft dysfunction | 1 (10%) | 3 (13%) | 0.8055 | |
Outcomes | Length of ICU stay (day) | 8 (6–13) | 16 (11–26) | 0.0025 |
Length of hospital stay (day) | 30 (22–47) | 60 (45–90) | 0.0040 | |
7 days total discharge (L) | 6.7 (3.3–18.7) | 32.6 (19.5–42.6) | 0.0003 | |
14 days total discharge (L) | 7.8 (3.3–27.8) | 68.7 (44.6–80.5) | < 0.0001 |